• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氧氯普胺致使用哌甲酯的儿童快速发作性精神病:一例报告

Metoclopramide-induced rapid-onset psychosis in a child with methylphenidate use: a case report.

作者信息

İlçioğlu Ekici Gökçen, Şenses Dinç Gülser, Çıtak Kurt Ayşegül Neşe

机构信息

Department of Child and Adolescent Psychiatry, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University Faculty of Medicine, Ankara, Türkiye.

Department of Child and Adolescent Psychiatry, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Türkiye.

出版信息

Turk J Pediatr. 2024 Dec 25;66(6):775-780. doi: 10.24953/turkjpediatr.2024.5319.

DOI:10.24953/turkjpediatr.2024.5319
PMID:39807731
Abstract

BACKGROUND

Metoclopramide, a dopamine antagonist employed for its antiemetic effects, can precipitate neuropsychiatric adverse effects, including extrapyramidal symptoms and, in a few instances, acute psychosis. Although there have been reports of metoclopramide-induced psychosis in elderly individuals, there is no documentation of such incidents in children as far as we are aware.

CASE PRESENTATION

This case report describes an 11-year-old girl with a history of mild intellectual disability and attention deficit hyperactivity disorder, managed with 10 mg of methylphenidate daily. She presented to the emergency department with acute gastrointestinal symptoms and was administered two tablets of metoclopramide alongside her regular dose of methylphenidate. Subsequently, she developed psychotic symptoms, disorganized behavior, and agitation. An extensive medical evaluation ruled out other organic pathologies, leading to a diagnosis of rapid-onset psychosis induced by metoclopramide. The psychotic episode, which lasted approximately two weeks, resolved with low-dose antipsychotic treatment.

CONCLUSIONS

Children, especially those with neurodevelopmental disorders, are more susceptible to a wide range of side effects. Therefore, this report highlights the necessity for careful pharmacological management. Additionally, this case represents a significant contribution to the scientific literature by being the first to document metoclopramide-induced acute psychosis in children to the best of our knowledge.

摘要

背景

甲氧氯普胺是一种用于止吐的多巴胺拮抗剂,可引发神经精神方面的不良反应,包括锥体外系症状,在少数情况下还会引发急性精神病。尽管有老年患者因甲氧氯普胺诱发精神病的报道,但据我们所知,尚无儿童发生此类事件的记录。

病例介绍

本病例报告描述了一名11岁女孩,有轻度智力残疾和注意力缺陷多动障碍病史,每天服用10毫克哌甲酯。她因急性胃肠道症状前往急诊科就诊,在服用常规剂量哌甲酯的同时,还服用了两片甲氧氯普胺。随后,她出现了精神病症状、行为紊乱和躁动。全面的医学评估排除了其他器质性病变,最终诊断为甲氧氯普胺诱发的快速起病型精神病。这一持续约两周的精神病发作,经低剂量抗精神病药物治疗后得到缓解。

结论

儿童,尤其是患有神经发育障碍的儿童,更容易出现各种副作用。因此,本报告强调了谨慎进行药物管理的必要性。此外,据我们所知,本病例是首例记录儿童因甲氧氯普胺诱发急性精神病的病例,对科学文献具有重要贡献。

相似文献

1
Metoclopramide-induced rapid-onset psychosis in a child with methylphenidate use: a case report.甲氧氯普胺致使用哌甲酯的儿童快速发作性精神病:一例报告
Turk J Pediatr. 2024 Dec 25;66(6):775-780. doi: 10.24953/turkjpediatr.2024.5319.
2
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
3
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
4
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
5
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
6
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.速释型哌甲酯用于治疗成人注意力缺陷多动障碍(ADHD)
Cochrane Database Syst Rev. 2014 Sep 18(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.
7
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
8
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
9
Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial.哌甲酯与安慰剂治疗晚期癌症患者疲劳的疗效比较:MePFAC随机对照试验
Health Technol Assess. 2025 Jul;29(36):1-47. doi: 10.3310/GJPS6321.
10
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.三环类抗抑郁药用于儿童和青少年注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD006997. doi: 10.1002/14651858.CD006997.pub2.